- Home
- PFE
PFE
Pfizer Inc.
as of 12-26-2025 3:57pm EST
$25.11
+$0.05
+0.22%
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 145.4B | IPO Year: | N/A |
| Target Price: | $27.40 | AVG Volume (30 days): | 48.3M |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.73 | EPS Growth: | 131.89 |
| 52 Week Low/High: | $20.91 - $27.69 | Next Earning Date: | 02-03-2026 |
| Revenue: | $62,785,000,000 | Revenue Growth: | 3.89% |
| Revenue Growth (this year): | -1.26% | Revenue Growth (next year): | -1.70% |
AI-Powered PFE Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 75.63%
75.63%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
Motley Fool
3 Superb High-Yield Dividend Stocks With Yields North of 5% That Make for No-Brainer Buys Right Now
📈
AI Sentiment
Highly Positive
8/10
Barrons.com
This Beaten-Down Pharma Stock Could Make a Turnaround in the New Year
âž–
AI Sentiment
Neutral
4/10
Investor's Business Daily
This Cancer-Fighting Biotech Surges Into Buy Zone As Earnings Soar 131%
📊
AI Sentiment
Positive
7/10
Zacks
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath?
📈
AI Sentiment
Highly Positive
8/10
Zacks
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
âž–
AI Sentiment
Neutral
4/10
Zacks
Can J&J's Pipeline Progress in 2025 Aid Long-Term Growth?
📈
AI Sentiment
Highly Positive
9/10
Barchart
As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?
📊
AI Sentiment
Positive
6/10
Compare PFE vs Leading Stocks
See how PFE stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.